Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 5537-5545, December 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barr, L. F.
Right arrow Articles by Dang, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barr, L. F.
Right arrow Articles by Dang, C. V.

Association of the Decreased Expression of {alpha}3ß1 Integrin with the Altered Cell: Environmental Interactions and Enhanced Soft Agar Cloning Ability of c-myc-overexpressing Small Cell Lung Cancer Cells1

Linda F. Barr2, Susan E. Campbell, Bruce S. Bochner and Chi V. Dang

Departments of Medicine [L. F. B., S. E. C., B. S. B., C. V. D.] and Oncology [L. F. B., C. V. D.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

Small cell lung cancer (SCLC) is a highly invasive and metastatic tumor, and the decreased expression of {alpha}3ß1 integrin may contribute to its virulence. {alpha}3ß1 is a critical integrin for pulmonary development and epithelial integrity, and its reduced expression has been linked to the increased malignancy and invasion of other cancers. The amplification of the c-myc oncogene is seen frequently in relapsed SCLC tumors and is associated with a worsened prognosis. In the present study using a model of SCLC tumor progression, overexpression of c-myc in a classic SCLC cell line, NCI H209, enhanced in vitro features of tumorigenesis, altered the relationships between cell and environment, and markedly down-regulated the expression of the {alpha}3 integrin subunit at both the transcript and protein levels. This inverse relationship between the expression of the {alpha}3 integrin subunit and c-myc is mimicked by other c-myc-overexpressing SCLC cell lines. Restoring {alpha}3 expression in the myc-transfected 209 cells reversed the effects of c-myc: {alpha}3 transfection increased cell:cell adhesion and reduced soft agar cloning without affecting the in vitro doubling time. The diminished soft agar cloning produced by {alpha}3 transfection was reversed by an antibody that specifically engages {alpha}3ß1 integrins, P1B5. These results suggest first, that {alpha}3ß1 integrin mediates homotypic adhesion of SCLC cells, and second, that unengaged {alpha}3ß1 integrin suppresses the growth of disaggregated SCLC cells. Thus, the down-regulation of the {alpha}3 integrin subunit may contribute to the enhanced tumorigenicity of c-myc-overexpressing SCLCs by allowing the growth of tumor cells that have reduced contact with ligand-expressing substratum or cells, a condition that occurs during the growth of the primary tumor, tumor invasion, and metastasis.

1 Supported by NIH K11 CA01685 and American Cancer Society IRG 58-005-39-IRG (to L. F. B.); NIH R01 CA57341 (to C. V. D.); and P01 HL 49545 (to B. S. B.)

2 To whom requests for reprints should be addressed, at Division of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 910, Baltimore, MD 21287. Phone: (410) 955-3467; Fax: (410) 955-0036; E-mail: jadams@welchlink.welch.jhu.edu.

Received 5/22/98. Accepted 10/ 5/98.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. V. Volpe, E. Chung, J. P. Ulm, B. F. Gilchrist, S. Ralston, K. T. Wang, and H. C. Nielsen
Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L143 - L152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Wang, Z. Zhang, Z. Zhang, H. Vikis, Y. Yan, Y. Wang, and M. You
Fine Mapping and Candidate Gene Analyses of Pulmonary Adenoma Resistance 1, a Major Genetic Determinant of Mouse Lung Adenoma Resistance
Cancer Res., March 15, 2007; 67(6): 2508 - 2516.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Frye, C. Gardner, E. R. Li, I. Arnold, and F. M. Watt
Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment
Development, June 15, 2003; 130(12): 2793 - 2808.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F Decline and P Rousselle
Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain
J. Cell Sci., January 2, 2001; 114(4): 811 - 823.
[Abstract] [PDF]


Home page
Cancer Res.Home page
L. F. Barr, S. E. Campbell, G. B. Diette, E. W. Gabrielson, S. Kim, H. Shim, and C. V. Dang
c-Myc Suppresses the Tumorigenicity of Lung Cancer Cells and Down-Regulates Vascular Endothelial Growth Factor Expression
Cancer Res., January 1, 2000; 60(1): 143 - 149.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.